Cargando…
Synergistic Anticancer Effects of Silibinin and Chrysin in T47D Breast Cancer Cells
OBJECTIVE: Breast cancer is one of the most significant causes of female cancer death worldwide. Although several chemotherapeutics have been developed to treat this type of cancer, issues remain such as low survival rates and high reoccurrence after chemotherapy and radiotherapy. To explore a chemo...
Autores principales: | Maasomi, Zahra Javan, Soltanahmadi, Younes Pilehvar, Dadashpour, Mehdi, Alipour, Shahriar, Abolhasani, Somayeh, Zarghami, Nosratollah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5555536/ https://www.ncbi.nlm.nih.gov/pubmed/28610415 http://dx.doi.org/10.22034/APJCP.2017.18.5.1283 |
Ejemplares similares
-
Effects of Chrysin-PLGA-PEG Nanoparticles on Proliferation and Gene Expression of miRNAs in Gastric Cancer Cell Line
por: Mohammadian, Farideh, et al.
Publicado: (2016) -
Combination of metformin and phenformin synergistically inhibits proliferation and hTERT expression in human breast cancer cells
por: Jafari-Gharabaghlou, Davoud, et al.
Publicado: (2018) -
Anticancer Potential of Silibinin Loaded Polymeric Nanoparticles against Breast Cancer Cells: Insight into the Apoptotic Genes Targets
por: Pourgholi, Ali, et al.
Publicado: (2021) -
Development of a Magnetic Nanostructure for Co-delivery of Metformin and Silibinin on Growth of Lung Cancer Cells: Possible Action Through Leptin Gene and its Receptor Regulation
por: Salamni Javan, Elnaz, et al.
Publicado: (2022) -
Association between Serum Kalirin Levels and the KALRN gene rs9289231 Polymorphism in Early-Onset Coronary Artery Disease
por: Shafiei, Afsaneh, et al.
Publicado: (2018)